CTLA4 and cancer: Cancer treatment in the last decade has hugely been the introduction of T cell-targeted immunomodulators blocking the immune checkpoints Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4), programmed cell death protein 1 (PD1) and PDL1 [151].